Von Willebrand factor human Completed Phase 4 Trials for Von Willebrand's Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02552576Study of Voncento® in Subjects With Von Willebrand Disease